Cart
sales@molnova.com
OBHSA
CAS No. 1404508-27-5
OBHSA( —— )
Catalog No. M37082 CAS No. 1404508-27-5
OBHSA（Oxabicycloheptane sulfonamide） is a novel selective estrogen receptor depressant (SERD) that can be used to study breast cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 459 | Get Quote |
|
| 10MG | 657 | Get Quote |
|
| 25MG | 1026 | Get Quote |
|
| 50MG | 1386 | Get Quote |
|
| 100MG | 1832 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | 3655 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOBHSA
-
NoteResearch use only, not for human use.
-
Brief DescriptionOBHSA（Oxabicycloheptane sulfonamide） is a novel selective estrogen receptor depressant (SERD) that can be used to study breast cancer.
-
DescriptionOBHSA（Oxabicycloheptane sulfonamide） is a novel selective estrogen receptor depressant (SERD) that can be used to study breast cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorEstrogen/progestogen Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1404508-27-5
-
Formula Weight547.54
-
Molecular FormulaC27H24F3NO6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(N(CC(F)(F)F)C1=CC=C(OC)C=C1)(=O)(=O)[C@@H]2[C@]3(C(=C([C@](O3)(C2)[H])C4=CC=C(O)C=C4)C5=CC=C(O)C=C5)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Depofemin
Estradiol cypionate is the 17 β-cyclopentylpropinate ester of estradiol, which inhibits ET-1 synthesis via estrogen receptor.
-
SLU-PP-332
SLU-PP-332 is a pan-estrogen receptor-related receptor (ERR) agonist with high affinity for ERRα, ERRβ, and ERRγ, exhibiting EC50 values of 98, 230, and 430 nM, respectively.
-
Medicarpin (b)
(+)-Medicarpin potently inhibits osteoclastogenesis and promotes bone healing and increases bone mass by osteoblast differentiation with estrogen receptor (ER) β-mediated osteogenic action.
